(616 Kb) Today

The researchers analyzed a large group of 616 patients with who were treated with ibrutinib. The goal was to see if the high success rates found in clinical trials were mirrored in everyday medical practice across various hospitals. Key Findings and Statistics

: Both groups had roughly the same time (about 85–87 months) from their initial diagnosis until they started ibrutinib treatment. Clinical Implications (616 KB)

Explain the specific (toxicities) that led to these discontinuations. Compare these results to more recent ibrutinib studies . The researchers analyzed a large group of 616